Company Analysis

Ironwood Pharmaceuticals, Inc. (IRWD)

Nasdaq: IRWD · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2008
Grade5.0
◀ Past 4.2● Present 5.0▶ Future 5.9

Who runs Ironwood Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Mccourt Thomas A
Chief Executive Officer. First filing Feb 2010, latest Mar 12, 2026, 33 filings in all.
Officers reporting now
8
of 15 people with a filing in the last fifteen months
Directors reporting now
7
34 people on the record since 2010
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Silber JeffreySVP, CMO, Head-Res&DrugJul 2026Jul 22, 2026none
Silver RonaldPFO & PAOJul 2021Jul 9, 20264 · $800,000
Currie Mark GChief Scientific OfficerFeb 2010Jun 17, 2026none
Mccourt Thomas AChief Executive OfficerFeb 2010Mar 12, 20262 · $700,000
Martini Gregory S.Chief Financial OfficerJan 2025Mar 12, 20262 · $100,000
Gaskins Tammi LChief Commercial OfficerMar 2025Mar 12, 20263 · $100,000
John MinardoChief Legal OfficerAug 2021Mar 12, 20262 · $100,000
Shetzline MichaelSVP, CMO, Head-Res&DrugApr 2020Mar 12, 20262 · $100,000
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Denner Alexander JdirectorNov 2020Sep 17, 20262 · $20.5M
Duane Jon RdirectorApr 2019Jun 17, 2026none
Kessler Marla LdirectorApr 2019Jun 17, 2026none
Mchugh JuliedirectorFeb 2014Jun 17, 20261 · $100,000
Moukheibir CatherinedirectorApr 2019Jun 17, 2026none
Shepard JaydirectorDec 2020Jun 17, 2026none
Sarissa Capital Management LPdirectorMar 2021Dec 17, 2025none
Earlier names on the record19, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton IRWD · research, not advice